1.A Case of Nasal Glioma.
Kyun Tae KIM ; Beom Joo LEE ; Sung Ku AHN ; Seung Hun LEE ; Won Soo LEE ; Soo Im CHOI
Annals of Dermatology 1994;6(2):215-218
No abstract available.
Glioma*
2.A Case of Bilateral Thalamic Glioma Presenting with Personality Change.
Kyung Bok LEE ; Jae Ha KIM ; Ji Yoon PARK ; Hakjae ROH ; Moo Young AHN
Journal of the Korean Neurological Association 2007;25(2):278-280
No abstract available.
Glioma*
3.KSPNO Protocol for Glioma.
Byung Kyu CHO ; Hye Lim JUNG ; Thad T GHIM ; Il Han KIM ; Yong Kil HONG ; Young Shin RA ; Mee Jeong LEE
Korean Journal of Pediatric Hematology-Oncology 2005;12(2):244-285
No abstract available.
Glioma*
4.Third Ventricular Chordoid Glioma: Case Report.
Sung Nam HWANG ; Seung Won PARK ; Young Baeg KIM ; Duck Young CHOI ; Mi Kyung KIM ; Shin Kwang KHANG
Journal of Korean Neurosurgical Society 2000;29(8):1103-1106
No abstract available.
Glioma*
5.Expression of the CYB561D2 gene in glioma tissue and its clinical significance
Journal of Apoplexy and Nervous Diseases 2024;41(2):148-151
Objective To investigate the expression and significance of the CYB561D2 gene in the prognostic evaluation of patients with glioma based on bioinformatics analysis. Methods A total of 78 pathological specimens were collected from the patients with glioma who received surgical treatment in Department of Neurosurgery，Anqing Municipal Hospital，from October 2018 to December 2022 and were enrolled as experimental group，and 32 specimens of normal brain tissue that must be removed during the surgical pathway were enrolled as control group. Quantitative real-time PCR and immunohistochemistry were used to measure the mRNA and protein expression levels of the CYB561D2 gene in both groups. Results The CYB561D2 gene was highly expressed in the glioma tissue of the patients in the experimental group，and the pathological grade of the tumor increased with the increase in the expression of the CYB561D2 gene，while there were no significant mRNA and protein expression levels of the CYB561D2 gene in the control group，with significant differences between the two groups（χ2=2.75 and 2.19，P<0.05）. Conclusion There are significant increases in the mRNA and protein expression levels of the CYB561D2 gene in glioma，suggesting that CYB561D2 is associated with the development，progression，and malignancy of glioma.
Glioma
6.Growth Suppression by Adenovirus-mediated Gene Transfer of p16/INK4a in Glioma Cell Lines.
Mi Suk KIM ; Hee Chung KWON ; Hee Seog KANG ; In Chul PARK ; Chang Hun RHEE ; Chang Min KIM ; Choon Taek LEE ; Seok Il HONG ; Seung Hoon LEE
Journal of Korean Neurosurgical Society 2000;29(4):471-476
No abstract available.
Cell Line*
;
Glioma*
8.Reversible Bilateral Striatal Hypermetabolism in a Patient with Leucine-Rich Glioma Inactivated-1 Encephalitis.
Aastha TAKKAR ; Aditya CHOUDHARY ; Bhagwan RAM MITTAL ; Vivek LAL
Journal of Clinical Neurology 2016;12(4):519-520
No abstract available.
Encephalitis*
;
Glioma*
;
Humans
9.Solitary Primary Leptomeningeal Glioma: Case Report.
Young Goo KIM ; Eui Hyun KIM ; Se Hoon KIM ; Jong Hee CHANG
Brain Tumor Research and Treatment 2013;1(1):36-41
We report a case of solitary primary leptomeningeal glioma. The mass was totally removed under awake surgery. Intraoperatively, no parenchymal involvement was noted. Histopathological study revealed a predominant anaplastic oligodendroglioma component and a focal anaplastic astrocytoma component, which was consistent with an anaplastic oligoastrocytoma. Adjuvant tomotherapy was followed and the tumor has not recurred until 12 months after surgery. A focal type of primary leptomeningeal glioma is extremely rare. We report a rare case of solitary primary leptomeningeal anaplastic oligoastrocytoma.
Astrocytoma
;
Glioma*
;
Oligodendroglioma
10.Clinical observation on brainstem glioma in childhood.
Hyun Jun CHO ; Se Hee HWANG ; Yong Seung HWANG ; In Won KIM
Journal of the Korean Pediatric Society 1991;34(4):532-543
No abstract available.
Brain Stem*
;
Glioma*
Result Analysis
Print
Save
E-mail